Top 20 Shareholders 30th December 2018
December Top_Holder_-_Detail_-_Single_Date
Top 20 Shareholders 14 December 2018
Top_Holders_Report (14)Download
PharmAust Manufacturing Method Maintains Drug Potency
440ws7dgb0lrfl
GMP Tablet Production for Clinical Trials Commences
181113_GMP Tablet Manufacture_44070bgt7qng63
2018 AGM Results
2018 AGM Results
2018 AGM Presentation
2018 AGM Presentation
Top 20 Shareholders 31st October 2018
Top_Holder_-_Detail_-_Single_Date October
Drug Reformulation Play With Significant Potential
2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…
GMP Method for PharmAust Analogue Pipeline
181029_GMP_AAD_Manufacture